Importance of investigation of myocardial metabolites in diagnosis and evaluation of treatment of ischaemic heart disease.
Myocardial metabolism was examined in 114 patients with ischaemic heart disease. In selected subgroups, possibilities were detected of using this method in clinical cardiological diagnostics for determining or defining more precisely the diagnosis of ischaemic heart disease, and for objective evaluation of conservative or surgical therapeutic approach in ischaemic heart disease.
D000328:Adult; D000787:Angina Pectoris / Q000378:metabolism; D006328:Cardiac Catheterization; D003326:Coronary Circulation; D003327:Coronary Disease / Q000175:diagnosis / Q000378:metabolism* / Q000628:therapy; D005260:Female; D006801:Humans; D007773:Lactates / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D009204:Myocardial Revascularization; D009206:Myocardium / Q000378:metabolism; D010069:Oxadiazoles / Q000627:therapeutic use; D011773:Pyruvates / Q000378:metabolism*; D019289:Pyruvic Acid; D014665:Vasodilator Agents / Q000627:therapeutic use
D007773:Lactates; D010069:Oxadiazoles; D011773:Pyruvates; D014665:Vasodilator Agents; D019289:Pyruvic Acid; C002787:imolamine